CDC Technology Transfer Office (TTO)

Display of pills and capsules in amber containers

The photo shows a CDC scientist implementing molecular testing, in order to test for different types of polio. CDC PHIL photo, James Gathany.

CDC investigator discussion with CDC Scientists

Collaborating with CDC Scientists

Overview

Our purpose: transferring CDC innovations into products to benefit public health

A laboratorian analyzes a participant sample under a laboratory hood in an acute febrile illness (AFI) research project.

Information for CDC Researchers on External Collaborations

Learn about collaborative opportunities available to CDC researchers. CDC PHIL photo, Nicholas Tenorio.

Researcher shown using CDC’s serologic test technology

Resources for Laboratories Working on Coronavirus (COVID-19)

A CDC scientist preparing an instrument to test patient samples for SARS-CoV-2 antibodies using the CDC serologic test. CDC PHIL photo, James Gathany.

About TTO

The Centers for Disease Control and Prevention Technology Transfer Office (TTO) partners with industry, academia, non-profits, and other government agencies to transfer CDC’s research portfolio into products and services to improve public health.

Available CDC Technologies

Collaborating with CDC

After staining the uninfected cells purple, the scientist will then count the clear spots on the plate, each representing a single virus particle. (Source: CDC PHIL.)

Interested in collaborating with CDC scientists? Visit our “For Industry” section to learn more about opportunities with CDC and find out how you can collaborate with CDC subject matter experts to help address unmet public health needs. CDC PHIL photo, Robert Denty.

Featured Technology

A three-dimensional (3D) computer-generated image is shown of a group of Gram-positive, Streptococcus pneumoniae bacteria. CDC has discovered encapsulated strains of commensal Streptococcus species that have capsules that are identical to pneumococcal capsules. From this, researchers developed compositions and methods from the species’ biosynthetic capsular genes which show promise for protecting people against pneumococcal disease, either by using these strains as vaccines or probiotics or through development of diagnostic assays.

Encapsulated Streptococcus Compositions and Methods for Pneumococcal Vaccine, Probiotic, and Diagnostic Assay Development. CDC PHIL photo, Dan Higgins.

Success Stories

A CDC researcher places samples into a real-time PCR (polymerase chain reaction) machine.

CDC scientists often provide solutions to unmet public health needs, by licensing or commercializing technologies. Here are a few ways CDC technologies have made an impact. CDC PHIL photo, James Gathany.

News & Events

CDC OTI staff participate in conferences including digital events. CDC photo, CDC OTI staff participate in conferences including digital events. CDC photo

CDC OTI staff participate in various conferences. Please ask our team members about CDC’s technology, Small Business Innovation Research (SBIR) Program, and collaboration opportunities.

Georgia Bio Innovation Summitexternal icon* – Virtual Conference, 11/4 – 11/6/20

Info for CDC Researchers

A CDC Polio Population Immunity team researcher loads completed serology assay plates into a microplate reader for analysis. The serology study was to support ongoing research with CDC’s clinical partners. The focus of the serology team is to advance development of new and improved polio vaccines. CDC Photo, James Gathany.

CDC Researchers interested in reporting new inventions, developing collaborative partnerships with outside parties, and beginning new agreements can visit our “For CDC Researchers” section to find out how to get started with CDC TTO’s assistance.

CDC Photo, James Gathany.

Page last reviewed: March 25, 2020

Content source: